Welcome to the United Nations 
64th session (12 - 16 April 2021), Vienna.
Report of the Commission on Narcotic Drugs on its sixty-fourth session [E/2021/28]
Resolutions/decisions adopted by the Council at the 2021 Management Segment as recommended by the Commission on its 64th session [E/2021/28, chap. I, sect. A; and E/2021/SR.13] 
19(d) 22 July 2021
Decision 2021/251: Report of the Commission on Narcotic Drugs on its sixty-fourth session and provisional agenda for its sixty-fifth session
Decision 2021/252: Report of the International Narcotics Control Board
Further resolutions and decisions adopted by CND on its 64th session [E/2021/28, chap. I, sect. B]:
Resolution 64/1: Statement of the Commission on Narcotic Drugs on the impact of the coronavirus disease (COVID-19) pandemic on the implementation of Member States’ joint commitments to address and counter all aspects of the world drug problem
Resolution 64/2: Promoting alternative development as a development-oriented drug control strategy, including in the context of the coronavirus disease (COVID-19) pandemic and its consequences
Resolution 64/3: Promoting scientific evidence-based, quality, affordable and comprehensive drug prevention, treatment, sustained recovery and related support services
Resolution 64/4: Improving data collection on, and responses to, the harmful effects of the non-medical use of pharmaceuticals containing narcotic drugs, psychotropic substances or new psychoactive substances
Resolution 64/5: Facilitating access to comprehensive, scientific evidence-based drug demand reduction services and related measures, including for people impacted by social marginalization
Decision 64/1: Inclusion of isotonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 64/2: Inclusion of CUMYL-PEGACLONE in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 64/3: Inclusion of MDMB-4en-PINACA in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 64/4: Inclusion of 3-methoxyphencyclidine in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 64/5: Inclusion of diphenidine in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 64/6: Inclusion of clonazolam in Schedule IV of the Convention on Psychotropic Substances of 1971
Decision 64/7: Inclusion of diclazepam in Schedule IV of the Convention on Psychotropic Substances of 1971
Decision 64/8: Inclusion of flubromazolam in Schedule IV of the Convention on Psychotropic Substances of 1971
Reconvened 63rd session (3 – 4 December 2020), Vienna.
Resolutions/decisions adopted by the Council at its 5th plenary meeting as recommended by the Commission at its reconvened 63rd session [E/2021/28/Add.1, chap. I, sect. A, and E/2021/SR.5] 19(d) 24 February 2021
Decision 2021/218: Improving the governance and financial situation of the United Nations Office on Drugs and Crime: extension of the mandate of the standing open ended intergovernmental working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime (draft decision I)
Decision 2021/220: Report of the Commission on Narcotic Drugs on its reconvened sixty-third session (draft decision II)
Further resources: